Patient adherence is a critical component in a clinical trial as it directly impacts validity of the clinical trial data. It also plays a pivotal role in deciding the outcome of clinical trials – in determining the drug’s efficacy and in receiving regulatory approval to launch the drug after establishing dosing guidelines. Patient adherence affects not only pharmaceutical manufacturers from a spend point of view, but also the scientific and regulatory community.

1. Patient Support /Enablement Programs
for Clinical Trial Adherence
Analysis of the mechanisms of non-adherence in a clinical trial
scenario and its Implications
Copyright © 2014 HCL Technologies Limited | www.hcltech.com

2. Low Adherence levels of Clinical Trials leads to worries
Increased Trial Costs:
 Increase in the recruitment of patients
 Increased time to complete a trial
Inaccurate and usually underestimated efficacy of new drugs
Limited accuracy and cost-effectiveness of Pharmacokinetics and
Pharmacodynamics analysis
Patient Enablement Solutions is the need of the hour
2 Copyright © 2014 HCL Technologies Limited | www.hcltech.com

3. There is an imminent need for a dedicated PEP
Stakeholders Benefitting out of
PEP:
Investigators/ site coordinators
Patients/ care-givers
CRO/ sponsors
Source: HCLTECH
3 Copyright © 2014 HCL Technologies Limited | www.hcltech.com

4. In this White paper you will find..
Patient enablement programs will definitely be the way forward as one of the crucial steps for ensuring trial
adherence. HCL has experience in successfully running Patient Support programs for leading Pharmaceutical majors
in various therapeutic areas and aims at delivering incomparable support in overcoming the challenges.
Challenges in Clinical Trial Adherence
Patient Support/ Enablement Programs: An Industry Perspective
HCL’s Patient Enablement solution for Clinical Trial Adherence
CLICK TO DOWNLOAD WHITE PAPER
4 Copyright © 2014 HCL Technologies Limited | www.hcltech.com